{
    "eid": "2-s2.0-85163001928",
    "title": "Long-term immunogenicity in previously vaccinated healthcare workers with inactivated virus vaccine after SARS-CoV-2 infection or booster vaccination",
    "cover-date": "2023-08-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Molecular Medicine",
            "@code": "1313",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Immunology and Microbiology (all)",
            "@code": "2400",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Veterinary (all)",
            "@code": "3400",
            "@abbrev": "VETE"
        },
        {
            "@_fa": "true",
            "$": "Public Health, Environmental and Occupational Health",
            "@code": "2739",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "CoronaVac",
        "COVID-19",
        "Hybrid immunity",
        "Immunogenicity",
        "Neutralizing antibodies"
    ],
    "authors": [
        "Varalee Terbsiri",
        "Opass Putcharoen",
        "Gompol Suwanpimolkul",
        "Watsamon Jantarabenjakul",
        "Supaporn Wacharapluesadee",
        "Nuntana Champa",
        "Nattakarn Thippamom",
        "Leilani Paitoonpong"
    ],
    "citedby-count": 0,
    "ref-count": 22,
    "ref-list": [
        "Short-term immune response after inactivated SARS-CoV-2 (CoronaVac\u00ae, Sinovac) and ChAdOx1 nCoV-19 (Vaxzevria\u00ae, Oxford-AstraZeneca) vaccinations in health care workers",
        "Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study",
        "Dynamics of Neutralizing Antibody and T-Cell Responses to SARS-CoV-2 and Variants of Concern after Primary Immunization with CoronaVac and Booster with BNT162b2 or ChAdOx1 in Health Care Workers",
        "COVID-19 Breakthrough Infection after Inactivated Vaccine Induced Robust Antibody Responses and Cross-Neutralization of SARS-CoV-2 Variants, but Less Immunity against Omicron",
        "A randomized clinical trial of a booster dose with low versus standard dose of AZD1222 in adult after 2 doses of inactivated vaccines",
        "Delta infection following vaccination elicits potent neutralizing immunity against the SARS-CoV-2 Omicron",
        "Neutralizing immunity against SARS-CoV-2 Omicron BA1 by infection and vaccination",
        "Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications",
        "A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity",
        "Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates",
        "2013 IDSA clinical practice guideline for vaccination of the immunocompromised host",
        "A new SARS-CoV-2 dual-purpose serology test: highly accurate infection tracing and neutralizing antibody response detection",
        "Evaluation of a SARS-CoV-2 surrogate virus neutralization test for detection of antibody in human, canine, cat, and hamster sera",
        "Effects of Inactivated Vaccination on Humoral Immune Responses in Patients Infected With Delta or Omicron Variants",
        "SARS-CoV-2 Omicron variant neutralization in serum from vaccinated and convalescent persons",
        "Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants",
        "Durability of neutralization against Omicron subvariants after vaccination and breakthrough infection",
        "Understanding \u2018hybrid immunity\u2019: comparison and predictors of humoral immune responses to SARS-CoV-2 infection and COVID-19 vaccines",
        "Structural and functional impact by SARS-CoV-2 Omicron spike mutations",
        "editors. Identification of natural SARS-CoV-2 infection in seroprevalence studies among vaccinated populations"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Chulalongkorn University"
    ]
}